Press
New Decision of the Paris High Court For Ethypharm Esomeprazole - July 11, 2011
The French pharmaceutical company Ethypharm has received, with great satisfaction, a new decision in its favour from the Paris High Court (Tribunal de Grand Instance) relating to its product esomeprazole, a generic of Inexium® for the treatment of gastroesophageal reflux disease. Download
Ethypharm - the first AEO-certified pharmaceutical company - March 29, 2011
On April 23rd, 2010, Ethypharm was the first pharmaceutical company to benefit from Custom Office simplifications by becoming “AEO” certified (Authorized Economic Operator). A year after this certification by the French Customs, Ethypharm draws a positive benefit from this global administrative deliverance procedure. Download
Cecile Paillous Appointed VP Corporate Quality - March 7, 2011
Cecile Paillous Appointed VP Corporate QualityCécile Paillous is appointed Vice President Corporate Quality of the pharmaceutical company Ethypharm. She becomes a member of the Executive Committee and reports to Hugues Lecat, Chairman and CEO of the Management Board. Download
Ethypharm Sells its Subsidiary in India - February 28, 2011
The pharmaceutical company Ethypharm sells all of its operations in India to Athena Pharm.
Ethypharm leaves India in order to refocus its activities on Europe, the United States, China and Japan; different markets where Ethypharm’s know-how and its competence in the development and registration sectors are renowned. Download
Bruno Delie Appointed Executive VP Business Development - February 7, 2011
Bruno Delie is appointed Executive Vice President Business Development of the pharmaceutical company Ethypharm. He is also a member of the Management Board and he reports to Hugues Lecat, Chairman and CEO of the Management Board. Download
Zhong Chongyu appointed General Manager of Ethypharm China - November 23, 2010
Zhong Chongyu (42) has been appointed General Manager of the pharmaceutical company Ethypharm in China. He reports to Alexandre Williams, Executive Vice President Business Development. Download
Frédéric Fougerat appointed Vice President Communications of Ethypharm - November 23, 2010
Frédéric Fougerat (44) has been appointed Vice President Communications of the pharmaceutical company Ethypharm. He is also a member of the Executive Committee and he reports to Hugues Lecat, Chairman & CEO of the Management Board. Download
2nd US product approval in 2010 for Ethypharm - September 27, 2010
PHILADELPHIA, PA September 27, 2010—Ethypharm USA Corp., announced today U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for buprenorphine HCl 2mg and 8mg sublingual tablets, the generic for Reckitt Benckiser’s Subutex® sublingual. Download
Ethypharm announces the launch of a new product on the US market - July 12, 2010
Ethypharm announces the commercial launch in the US of a new product using its Flashtab® technology. Tramadol Flashtab® is available since end of May, 2010. This new commercial launch confirms Ethypharm’s strong commitment to increase its presence on the North American market. Download
Ethypharm sells its subsidiary NP Pharm - April 20, 2010
Ethypharm announces the cession of its subsidiary NP PHARM to COLORCON, a company dedicated to the development, supply and technical support of formulated coatings and excipients for the pharmaceutical industry.
NP PHARM produces sugar spheres as excipients for the pharmaceutical industry. This Company, founded in 1992, of approx. 20 people, has reached a turnover of 5 Million Euros for the year 2009. Download
Ethypharm moves R&D activities from Canada to France - April 19, 2010
Ethypharm announces the cession of its r&D center in Laval (montreal), canada. the r&D center of Laval, certified by both canadian and american health authorities, was dedicated to the development of oral modified release form medicines and employed 31 people. Download
Hugues Lecat appointed Chairman & CEO of the Management Board of Ethypharm - February 10, 2010
M. Hugues Lecat has been appointed Chairman and CEO of the Management Board of the pharmaceutical company Ethypharm. Hugues Lecat, 53, graduated from the Ecole Superieure de Commerce in Rouen and holds an MBA from INSEAD. Download